Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 1/2018

01-10-2018 | Meta-Analysis

Association of type 2 diabetes susceptible genes GCKR, SLC30A8, and FTO polymorphisms with gestational diabetes mellitus risk: a meta-analysis

Authors: Ziqi Lin, Yue Wang, Bao Zhang, Zhen Jin

Published in: Endocrine | Issue 1/2018

Login to get access

Abstract

Purpose

Current studies have detected the correlation of polymorphisms in type 2 diabetes susceptible genes GCKR, SLC30A8 and FTO with gestational diabetes mellitus (GDM) risk. However, findings of these studies were incongruous. Hence, we performed an integrated review and meta-analysis for the researches regarding the association of single nucleotide polymorphisms (SNPs) in GCKR, SLC30A8 and FTO genes and GDM risk.

Methods

Eligible publications were selected on the basis of several inclusion and exclusion criteria. Correlation between each SNP and GDM risk was estimated by computing odds ratios (ORs) with 95% confidence intervals (95%CIs).

Results

Consequently, 19 case-control studies (from 16 citations) including 3636 GDM cases and 7229 GDM-free controls were participated in a meta-analysis of seven prevalent SNPs (GCKR rs1260326 and rs780094; SLC30A8 rs13266634 and rs11558471; FTO rs8050136, rs1421085 and rs9939609). Our results demonstrated that the rs780094, rs13266634 and rs9939609 SNPs were significantly associated with GDM risk. In stratified analysis, correlations of rs780094 and rs13266634 SNPs could be observed in Asian and Caucasian subgroups. Moreover, association between rs9939609 SNP and GDM risk was detected in Caucasian subgroup.

Conclusions

The GCKR rs780094, SLC30A8 rs13266634 and FTO rs9939609 SNPs were demonstrated to be the potential biomarkers for GDM risk prediction.
Appendix
Available only for authorised users
Literature
1.
J. Brown et al. Lifestyle interventions for the treatment of women with gestational diabetes. Cochrane Database Syst. Rev. 5, CD011970 (2017)PubMed
2.
E.A. Reece, G. Leguizamon, A. Wiznitzer, Gestational diabetes: the need for a common ground. Lancet 373(9677), 1789–1797 (2009)CrossRefPubMed
3.
E.A.R. Goedegebure et al. Pregnancy outcomes in women with gestational diabetes mellitus diagnosed according to the WHO-2013 and WHO-1999 diagnostic criteria: a multicentre retrospective cohort study. BMC Pregnancy Childbirth 18(1), 152 (2018)CrossRefPubMedPubMedCentral
4.
Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res. Clin. Pract. 103(3), 341–363 (2014)
5.
M. Hod et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int. J. Gynaecol. Obstet. 131, S173–S211 (2015)CrossRefPubMed
6.
A. Ferrara, Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 30, S141–S146 (2007)CrossRefPubMed
7.
Y. Zhu, C. Zhang, Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr. Diab. Rep. 16(1), 7 (2016)CrossRefPubMed
8.
L. Bellamy et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373(9677), 1773–1779 (2009)CrossRefPubMed
9.
Y. Zhang et al. Vitamin D and gestational diabetes mellitus: a systematic review based on data free of Hawthorne effect. BJOG 125(7), 784–793 (2017)CrossRef
10.
L. Chen, D.J. Magliano, P.Z. Zimmet The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat. Rev. Endocrinol. 8(4), 228–236 (2011)CrossRefPubMed
11.
A.O. Martin et al. Frequency of diabetes mellitus in mothers of probands with gestational diabetes: possible maternal influence on the predisposition to gestational diabetes. Am. J. Obstet. Gynecol. 151(4), 471–475 (1985)CrossRefPubMed
12.
L.J. Scott et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316(5829), 1341–1345 (2007)CrossRefPubMedPubMedCentral
13.
S. Su et al. The association between leptin receptor gene polymorphisms and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Res. Clin. Pract. 121, 49–58 (2016)CrossRefPubMed
14.
15.
R. Saucedo et al. Gene variants in the FTO gene are associated with adiponectin and TNF-alpha levels in gestational diabetes mellitus. Diabetol. Metab. Syndr. 9, 32 (2017)CrossRefPubMedPubMedCentral
16.
M. Tarnowski et al. GCK, GCKR, FADS1, DGKB/TMEM195 and CDKAL1 gene polymorphisms in women with gestational diabetes. Can. J. Diabetes 41(4), 372–379 (2017)CrossRefPubMed
17.
X. Wang et al. Investigation of miRNA-binding site variants and risk of gestational diabetes mellitus in Chinese pregnant women. Acta Diabetol. 54(3), 309–316 (2017)CrossRefPubMed
18.
O. Anderka et al. Biophysical characterization of the interaction between hepatic glucokinase and its regulatory protein: impact of physiological and pharmacological effectors. J. Biol. Chem. 283(46), 31333–31340 (2008)CrossRefPubMed
19.
F. Chimienti et al. In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J. Cell. Sci. 119(Pt 20), 4199–4206 (2006)CrossRefPubMed
20.
21.
T. Abarin et al. The impact of breastfeeding on FTO-related BMI growth trajectories: an application to the Raine pregnancy cohort study. Int. J. Epidemiol. 41(6), 1650–1660 (2012)CrossRefPubMed
22.
A. Stang, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 25(9), 603–605 (2010)CrossRefPubMed
23.
N. Mantel, W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22(4), 719–748 (1959)PubMed
24.
R. DerSimonian, N. Laird, Meta-analysis in clinical trials. Control. Clin. Trials 7(3), 177–188 (1986)CrossRefPubMed
25.
F.M. Matschinsky, B. Glaser, M.A. Magnuson, Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities. Diabetes 47(3), 307–315 (1998)CrossRefPubMed
26.
M. Orho-Melander et al. Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes 57(11), 3112–3121 (2008)CrossRefPubMedPubMedCentral
27.
M.G. Rees et al. Correlation of rare coding variants in the gene encoding human glucokinase regulatory protein with phenotypic, cellular, and kinetic outcomes. J. Clin. Invest. 122(1), 205–217 (2012)CrossRefPubMed
28.
M.I. Anghebem-Oliveira et al., The GCKR gene polymorphism rs780094 is a risk factor for gestational diabetes in a Brazilian population. J. Clin. Lab. Anal. 31(2) (2017)CrossRef
29.
N.A. Seman et al. Increased DNA methylation of the SLC30A8 gene promoter is associated with type 2 diabetes in a Malay population. Clin. Epigenetics 7, 30 (2015)CrossRefPubMedPubMedCentral
30.
T. Sparso et al. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. Diabetologia 51(1), 70–75 (2008)CrossRefPubMed
31.
A.M. Stuebe et al. Maternal genotype and gestational diabetes. Am. J. Perinatol. 31(1), 68–76 (2014)
32.
F. Chimienti et al. Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 53(9), 2330–2337 (2004)CrossRefPubMed
33.
Y. Fu et al. Down-regulation of ZnT8 expression in INS-1 rat pancreatic beta cells reduces insulin content and glucose-inducible insulin secretion. PLoS. One. 4(5), e5679 (2009)CrossRefPubMedPubMedCentral
34.
M. Tamaki et al. Downregulation of ZnT8 expression in pancreatic beta-cells of diabetic mice. Islets 1(2), 124–128 (2009)CrossRefPubMed
35.
J. Dereke et al. The prevalence and predictive value of the SLC30A8 R325W polymorphism and zinc transporter 8 autoantibodies in the development of GDM and postpartum type 1 diabetes. Endocrine 53(3), 740–746 (2016)CrossRefPubMed
36.
S. Carvalho et al. Differential cytolocation and functional assays of the two major human SLC30A8 (ZnT8) isoforms. J. Trace Elem. Med. Biol. 44, 116–124 (2017)CrossRefPubMed
37.
I. Kim et al. A low-risk ZnT-8 allele (W325) for post-transplantation diabetes mellitus is protective against cyclosporin A-induced impairment of insulin secretion. Pharm. J. 11(3), 191–198 (2011)
38.
T.J. Nicolson et al. Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes 58(9), 2070–2083 (2009)CrossRefPubMedPubMedCentral
39.
J. Lauenborg et al. Common type 2 diabetes risk gene variants associate with gestational diabetes. J. Clin. Endocrinol. Metab. 94(1), 145–150 (2009)CrossRefPubMed
40.
A. Teleginski et al. Leptin (rs7799039) and solute carrier family 30 zinc transporter (rs13266634) polymorphisms in Euro-Brazilian pregnant women with gestational diabetes. Genet. Mol. Res. 16(1) (2017)
41.
T.M. Frayling et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316(5826), 889–894 (2007)CrossRefPubMedPubMedCentral
42.
R.J. Loos, C. Bouchard FTO: the first gene contributing to common forms of human obesity. Obes. Rev. 9(3), 246–250 (2008)CrossRefPubMed
43.
44.
M. Franzago et al. Nutrigenetic variants and cardio-metabolic risk in women with or without gestational diabetes. Diabetes Res. Clin. Pract. 137, 64–71 (2018)CrossRefPubMed
45.
Y. Yang et al. FTO genotype and type 2 diabetes mellitus: spatial analysis and meta-analysis of 62 case-control studies from different regions. Genes 8(2) (2017)CrossRefPubMedCentral
46.
M. Rivera et al. Interaction between the FTO gene, body mass index and depression: meta-analysis of 13701 individuals. Br. J. Psychiatry 211(2), 70–76 (2017)CrossRefPubMedPubMedCentral
47.
S. Jamalpour et al. A case-control study and meta-analysis confirm glucokinase regulatory gene rs780094 is a risk factor for gestational diabetes mellitus. Gene 125(7):784-793 (2018)
48.
49.
M. Franzago et al. Molecular analysis of a genetic variants panel related to nutrients and metabolism: association with susceptibility to gestational diabetes and cardiometabolic risk in affected women. J. Diabetes Res. 2017, 4612623 (2017)CrossRefPubMedPubMedCentral
50.
M.I. Anghebem-Oliveira et al. Type 2 diabetes-associated genetic variants of FTO, LEPR, PPARg, and TCF7L2 in gestational diabetes in a Brazilian population. Arch. Endocrinol. Metab. 61(3), 238–248 (2017)CrossRefPubMed
51.
S.F. de Melo et al. Polymorphisms in FTO and TCF7L2 genes of Euro-Brazilian women with gestational diabetes. Clin. Biochem. 48(16-17), 1064–1067 (2015)CrossRefPubMed
52.
A. Pagan et al. A gene variant in the transcription factor 7-like 2 (TCF7L2) is associated with an increased risk of gestational diabetes mellitus. Int. J. Endocrinol. 180, 77–82 (2014)
53.
M. He et al. Association of rs13266634 polymorphism in zinc transporter solute carrier family 30-member 8 gene with gestational diabetes mellitus. Chin. J. Diabetes Mellit. 5(1), 38–43 (2013)
54.
Y.M. Cho et al. Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia 52(2), 253–261 (2009)CrossRefPubMed
Metadata
Title
Association of type 2 diabetes susceptible genes GCKR, SLC30A8, and FTO polymorphisms with gestational diabetes mellitus risk: a meta-analysis
Authors
Ziqi Lin
Yue Wang
Bao Zhang
Zhen Jin
Publication date
01-10-2018
Publisher
Springer US
Published in
Endocrine / Issue 1/2018
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1651-z

Other articles of this Issue 1/2018

Endocrine 1/2018 Go to the issue

Original Article

Pulmonary metastases in children and adolescents with papillary thyroid cancer in China: prognostic factors and outcomes from treatment with 131I

Original Article

FKBP5 expression in human adipose tissue: potential role in glucose and lipid metabolism, adipogenesis and type 2 diabetes

Endocrine Surgery

Perioperative serum cortisol levels in ACTH sufficient and ACTH deficient patients during transsphenoidal surgery of pituitary adenoma

Original Article

Inhibition of endoplasmic reticulum stress by intermedin1-53 attenuates angiotensin II–induced abdominal aortic aneurysm in ApoE KO Mice

Endocrine Surgery

Great veins invasion in follicular thyroid cancer: single-centre study assessing prevalence and clinical outcome

Original Article

Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits